Depression is a common and chronic comorbidity in patients with interstitial lung disease

Respirology

Volumn 17, Issue 3, 2012, Pages 525-532

  Ryerson, Christopher J ^a   Arean, Patricia A ^b   Berkeley, Jane ^a   Carrieri Kohlman, Virginia L ^a   Pantilat, Steven Z ^a   Landefeld, C Seth ^a   Collard, Harold R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

depression; dyspnoea; interstitial lung disease; pain; sleep

Indexed keywords

ADULT; AGED; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DEPRESSION; DISEASE SEVERITY; DYSPNEA; FEMALE; FOLLOW UP; FORCED VITAL CAPACITY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PAIN; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING; SLEEP QUALITY;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; DEPRESSION; DYSPNEA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; OXYGEN; PAIN; PREVALENCE; PROSPECTIVE STUDIES; PSYCHOLOGICAL TESTS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS; VITAL CAPACITY;

EID: 84859079773     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.02122.x     Document Type: Article

References (38)

1. Bjoraker JA, Ryu JH, Edwin MK, et al,. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 1998; 157: 199-203.
2. Hubbard R, Johnston I, Britton J,. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study. Chest 1998; 113: 396-400.
3. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med. 2002; 165: 277-304.
4. Vourlekis JS, Schwarz MI, Cherniack RM, et al,. The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis. Am. J. Med. 2004; 116: 662-8.
5. Cox CE, Donohue JF, Brown CD, et al,. Health-related quality of life of persons with sarcoidosis. Chest 2004; 125: 997-1004.
6. Thrall G, Lip GY, Carroll D, et al,. Depression, anxiety, and quality of life in patients with atrial fibrillation. Chest 2007; 132: 1259-64.
7. Riekert KA, Bartlett SJ, Boyle MP, et al,. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest 2007; 132: 231-7.
8. Ruo B, Rumsfeld JS, Hlatky MA, et al,. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 2003; 290: 215-21.
9. Katon W, Fan MY, Unutzer J, et al,. Depression and diabetes: a potentially lethal combination. J. Gen. Intern. Med. 2008; 23: 1571-5.
10. Carney RM, Blumenthal JA, Catellier D, et al,. Depression as a risk factor for mortality after acute myocardial infarction. Am. J. Cardiol. 2003; 92: 1277-81.
11. Blumenthal JA, Lett HS, Babyak MA, et al,. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 2003; 362: 604-9.
12. Frasure-Smith N, Lesperance F, Gravel G, et al,. Social support, depression, and mortality during the first year after myocardial infarction. Circulation 2000; 101: 1919-24.
13. Omachi TA, Katz PP, Yelin EH, et al,. Depression and health-related quality of life in chronic obstructive pulmonary disease. Am. J. Med. 2009; 122: 778.e9-15.
14. Ng TP, Niti M, Tan WC, et al,. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch. Intern. Med. 2007; 167: 60-67.
15. Hanania NA, Müllerova H, Locantore NW, et al,. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am. J. Respir. Crit. Care Med. 2011; 183: 604-11.
16. Lamers F, Jonkers CC, Bosma H, et al,. Improving quality of life in depressed COPD patients: effectiveness of a minimal psychological intervention. COPD 2010; 7: 315-22.
17. Ryerson CJ, Berkeley J, Carrieri-Kohlman VL, et al,. Depression and functional status are strongly associated with dyspnea in interstitial lung disease. Chest 2011; 139: 609-16.
18. De Vries J, Kessels BL, Drent M,. Quality of life of idiopathic pulmonary fibrosis patients. Eur. Respir. J. 2001; 17: 954-61.
19. Lacasse Y, Selman M, Costabel U, et al,. Clinical diagnosis of hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 2003; 168: 952-8.
20. American Thoracic Society (ATS), European Respiratory Society (ERS), World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG). Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am. J. Respir. Crit. Care Med. 1999; 160: 736-55.
21. Radloff L,. The CES-D Scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977; 1: 385-401.
22. Eakin EG, Resnikoff PM, Prewitt LM, et al,. Validation of a new dyspnea measure: the UCSD shortness of breath questionnaire. University of California, San Diego. Chest 1998; 113: 619-24.
23. Daut RL, Cleeland CS, Flanery RC,. Development of the Wisconsin brief pain questionnaire to assess pain in cancer and other diseases. Pain 1983; 17: 197-210.
24. Cleeland CS, Ryan KM,. Pain assessment: global use of the brief pain inventory. Ann. Acad. Med. Singapore 1994; 23: 129-38.
25. Buysse DJ, Reynolds CF, 3rd, Monk TH, et al,. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989; 28: 193-213.
26. Macintyre N, Crapo RO, Viegi G, et al,. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur. Respir. J. 2005; 26: 720-35.
27. Miller MR, Hankinson J, Brusasco V, et al,. Standardisation of spirometry. Eur. Respir. J. 2005; 26: 319-38.
28. Rantanen T, Guralnik JM, Foley D, et al,. Midlife hand grip strength as a predictor of old age disability. JAMA 1999; 281: 558-60.
29. Guralnik JM, Ferrucci L, Pieper CF, et al,. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J. Gerontol. A. Biol Sci. Med Sci 2000; 55: M221-31.
30. Royston P,. Multiple imputation of missing values. Stata J. 2004; 4: 227-41.
31. Graham JW, Olchowski AE, Gilreath TD,. How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev. Sci. 2007; 8: 206-13.
32. Ferreira A, Garvey C, Connors GL, et al,. Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response. Chest 2009; 135: 442-7.
33. Posternak MA, Solomon DA, Leon AC, et al,. The naturalistic course of unipolar major depression in the absence of somatic therapy. J. Nerv. Ment. Dis. 2006; 194: 324-9.
34. Spangler JG, Summerso JH, Bell RA, et al,. Smoking status and psychosocial variables in type 1 diabetes mellitus. Addict. Behav. 2001; 26: 21-9.
35. Bonnet F, Irving K, Terra JL, et al,. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis 2005; 178: 339-44.
36. Lasser K, Boyd JW, Woolhandler S, et al,. Smoking and mental illness: a population-based prevalence study. JAMA 2000; 284: 2606-10.
37. Husky MM, Mazure CM, Paliwal P, et al,. Gender differences in the comorbidity of smoking behavior and major depression. Drug Alcohol Depend. 2008; 93: 176-9.
38. Glassman AH, Covey LS, Stetner F, et al,. Smoking cessation and the course of major depression: a follow-up study. Lancet 2001; 357: 1929-32.